Isatin dimers and their biological activities
Ya-Zhou Zhang1, Hong-Zhi Du1, Hai-Lin Liu1
1Teaching and Research Office of Analytical Chemistry, School of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guizhou, China.
Abstract:
Dimerization is a promising strategy to develop novel drug candidates that could extend the biological spectrum, enhance the activity, overcome drug resistance, as well as improve pharmacological, pharmacokinetic, and physicochemical profiles. Isatin dimers possess a broad spectrum of biological properties and the isatin dimer indirubin has already been used in the clinic, revealing the potential of isatin dimers as putative drugs. This review covers the recent advances of isatin dimers as pharmacologically significant scaffolds and the structure-activity relationship to set up the direction for the design and development of isatin dimers with higher efficiency and lower toxicity.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
The JAK-STAT Signaling Pathway
Enzyme Inhibition
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Stereoisomers
Stability of Conjugated Dienes
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.


